Skip to main content
GRI Bio, Inc. logo

GRI Bio, Inc. — Investor Relations & Filings

Ticker · GRI ISIN · US3622AW4030 US Manufacturing
Open in API
Filings indexed 371 across all filing types
Latest filing 2026-05-14 Regulatory Filings
Country US United States of America
Listing US GRI

About GRI Bio, Inc.

https://www.gribio.com/

GRI Bio, Inc. is a clinical-stage biopharmaceutical company that develops therapies for inflammatory, fibrotic, and autoimmune diseases. The company's primary focus is on advancing its pipeline of Natural Killer T (NKT) cell modulators. This therapeutic strategy targets the initial stages of the inflammatory cascade, aiming to interrupt disease progression and fundamentally alter the treatment of these conditions.

Recent filings

Filing Released Lang Actions
8-K
Regulatory Filings Classification · 90% confidence The document is a Form 8-K Current Report filed under Section 13/15(d) of the Exchange Act, furnishing an earnings press release as Exhibit 99.1. It does not contain the full financial statements itself but serves as a regulatory filing to report the event. There is no dedicated category for Form 8-K; under the taxonomy this is best classified as a general regulatory announcement (RNS).
2026-05-14 English
10-Q - GRI Bio, Inc. (0001824293) (Filer)
Interim / Quarterly Report Q1 2026
2026-05-13 English
SCHEDULE 13G/A Filing
Major Shareholding Notification
2026-02-10 English
8-K Filing
Regulatory Filings Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, dated February 4, 2026. It reports the issuance of a press release reiterating financial results for fiscal year 2025 and summarizes key recent highlights. The document explicitly states that the press release is furnished as an exhibit and is not "filed" for certain regulatory purposes. The document length is 3652 characters, which is relatively short and mainly serves as an announcement of the press release rather than containing detailed financial statements or analysis itself. According to the 'Menu vs Meal' rule, this is an announcement of a report (the press release) rather than the report itself. Therefore, the appropriate classification is Regulatory Filings (RNS), which is the fallback for miscellaneous filings that do not fit other categories and includes such announcements.
2026-02-04 English
8-K - GRI BIO, INC. (0001824293) (Filer)
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, dated January 29, 2026. It reports an amendment to an At The Market Offering Agreement to increase the aggregate offering price of shares. The document includes legal opinions and the amendment agreement as exhibits. There are no financial statements or detailed financial data presented, only a description of a financing agreement amendment. This type of filing is an update on capital raising activities and changes to financing agreements, which fits the Capital/Financing Update category. The document length is 5266 characters, sufficient to contain substantive information about the financing update rather than just an announcement. Therefore, the correct classification is Capital/Financing Update (CAP).
2026-01-30 English
S-3 - GRI BIO, INC. (0001824293) (Filer)
Capital/Financing Update Classification · 100% confidence The document is a Form S-3 Registration Statement filed with the SEC, which is a shelf registration statement used to register securities for sale to the public. It includes a prospectus describing the securities to be offered, the terms of the offering, and other related information. This type of filing is related to capital raising activities and financing. It is not an annual report, earnings release, or any other type of financial or governance report. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length is substantial (15,000 characters), and it contains detailed registration and offering information, not just an announcement or a brief notice, so it is not RPA or RNS.
2026-01-30 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.